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Abstract
Labor conditions of junior medical staff at oncological institutions and risks arising in the course of their work are presented in
the present article.
Topicality. Monitoring of hygienic labor conditions conducted at cancer oncological institutions of Ukraine has shown that
80-85% of junior medical staff’s work conditions do not meet the requirements of occupational health and safety standards
and therefore refer to work under harmful and dangerous conditions.
Taking into account the above mentioned information, the research focused on health protection of junior medical staff during
work with carcinogens as well as introduction of newest health and safety procedures into learning process is very actual and
prospective.
Problem statement. Most anticancer drugs used for oncology patients’ treatment have significant non-selective, toxic effects
on the body as well as mutagenic, carcinogenic influence. However, not only treated patient’s organism is affected by such
exposure but junior medical staff preparing, administrating and doing utilization of drugs as well. Therefore, this category
of medical staff needs maximal protection. Their working conditions also require maximal control and correspondence to
occupational safety rules.
The objective of the research was to substantiate the necessity of introduction of questions related to occupational safety
during work with anticancer drugs into the syllabus of junior medical staff in order to provide safe working conditions.
The questions related with occupational safety during work with anticancer drugs should be also introduced to the learning
process of the discipline “Occupational safety in the field”. This will provide an opportunity to prevent and avoid the
development of work-related diseases, including occupational cancer among junior medical staff.
Conclusions and prospects for further research. Introduction of questions related to occupational safety during work with
anticancer drugs into the discipline “Occupational safety in the field” for junior specialists will allow to decrease the level of
work-related diseases and other professional pathology among junior medical staff during work with harmful oncogenic drugs.
The prospects of further researches involve developing of diet and preventive nutrition for junior medical staff working with
anticancer drugs development of new measures and methods of individual and collective protective measures from harmful
oncogenic drugs.
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Topicality
Monitoring of junior medical staff labor conditions in Ukrainian
oncological institutions has shown that 80-85 percent of them
do not meet occupational safety requirements and can be
referred to category of work with harmful and dangerous con-
ditions [1]. Therefore, the research in the field of occupational
health and protection of junior medical staff during work with
harmful oncogenic drugs (HOD) as well as implementation of
newest methods of labor protection into the learning process
are very topical and prospective approaches.
Problem statement and analysis of the
recent research
The majority of anticancer drugs used for oncological patients’
treatment have significant non selective, toxic impact on the or-
ganism as well as mutagenic and carcinogenic influence. How-
ever, not only patients but medical staff’s organisms undergo
such influence. Definitely, junior medical staff is affected
more intensively during drugs preparing, administration and
utilization. Therefore, such category of medical staff requires
maximal protection and control of labour conditions at their
workplaces should be the highest.
Researches dedicated to the origin and prevention of oc-
cupational cancer among medical workers were conducted by
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State Institution “Institute for occupational health of Academy
of Medical Sciences of Ukraine” and presented in scientific
publications of many Ukrainian and foreign authors. They in-
clude the studies by Y. Kundiev et al. [2, 3], D. V. Varivonchik
[4], D. V. Varivonchik et al. [5], V. I. Shevchenko [6], S.
Tuljandin et al. [7], T.H. Connor and M. A. McDiarmid [8],
B. W. Stewart and P. Kleihues [9], W. Fransman et al. [10], H.
Kromhout et al. [11], S. Krstev et al. [12].
According to the data of International Labour Organiza-
tion (ILO), occupational cancer morbidity is from 4.0 to 16.0
percent among all cases of malignant growth in countries with
high level of industry development.
Percentage of patients with occupational cancer among
the total amount of oncologic patients in Ukraine constitutes
only 0.001-0.04 percent, that is significantly lower than ILO
assessment. It shows that approximately 95 percent of de-
tected cases of occupational cancer in Ukraine are suppressed
[3].
Oncogenic drugs can pass into an organism in different
ways such as inhalation, thermal, oral, parenteral ones (Table
1).
Inhalation route is possible during inhaling of dust and
aerosols in the course of production, packing, transportation,
storing, solutions preparation, powdering of tablets as well as
during collecting, purification and utilization of medical prod-
ucts. Samples particles can spread by air after contaminated
surfaces drying.
Another potential route of transmission is drugs contact
with skin during entering into environment or touching of
contaminated surfaces in the course of preparing, usage or
drugs utilization.
Negative consequence for health of exposed workers is
increase in the risk of malignant tumor development such as
leukaemia, lymphoma, cancer of bladder, breast, skin, liver
etc.
Non-oncogenic consequences include:
• acute: alopecia toxica, allergic dermatosis;
• chronic: infertility, spontaneous abortion, recurrent mis-
carriage, congenital defects among workers’ children,
etc.
Highlighting of unsolved issue
Prevention of accidents, traumatism or occupational diseases
is known to be easier than their treatment or relief of the
consequences. Such necessary preventive measure could be
teaching of occupational safety principles during work with
HOD and target safety training at the workplaces to junior
medical staff.
Nevertheless, the problem of studying of professional
safety basics by junior medical staff at medical colleges is
unsolved. Supplementation of the discipline “Occupational
safety in the field” for junior specialists with questions related
with occupational safety during work with anticancer drugs is
essential as well as conduction of the researches in this field.
The objective of the research was to introduce the ques-
tions related to occupational safety during work with anti-
cancer drugs into the discipline “Occupational safety in the
field” for junior specialists. It allows prevention of occu-
pational diseases origin such as occupational cancer among
junior medical staff.
Basic matter statement
At the present stage an approach for occupational cancer pre-
vention is based on ILO Convention No139 “Occupational
Cancer Convention”, 1974. Convention concerns Prevention
and Control of Occupational Hazards caused by Carcinogenic
Substances and Agents (Entry into force: 10 Jun 1976). It
was ratified by Ukraine on the 10th of March 2010.
Realization of occupational cancer prevention measures
was implemented just partially in Ukraine during 1992-2015:
1. Statistic monitoring of patients with occupational can-
cer;
2. New version of hygienic standard “List of substances,
stuff, working processes and environmental factors which
are oncogenic for people” was implemented (2006) and
the work on its improvement and review is underway
(project of 2012);
3. Methods of oncogenic hazards assessment at the Ukrainian
factories were suggested;
4. Criteria for expert determination of occupational cancer
were offered;
5. Changes in the “List of occupational diseases” (2000)
in part “Occupational cancer” were made according to
new scientific data;
6. New version of “Procedure of medical examination of
specific categories of workers” was presented where
health monitoring program of workers under occupa-
tional exposure to cancirogens was provided;
7. Organizational standards of medical supervision for
workers related to exposure to cancirogens at work were
suggested [13].
The strategy concerning instruction of workers about labor
safety and measures decreasing occupational cancer failed.
We think that problem can be solved by organization of
periodical process of education at medical colleges and at the
workplaces for junior medical staff. Only workers who have
completed training in HOD safe using can be admitted for
work. Additional training and professional development tests
should be taken at least once a year.
This course should include information about:
1. Potential danger of HOD for workers who contact with
them;
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Table 1. Types of hazardous activity of medical staff in the course of work with HOD
Group’s name Types of hazardous activity
Nurses, paramedics
intramuscular, endermic, intravenous drugs administration;
drugs administration through infusion sets or automatic measuring devices;
collecting and utilization of wastes contaminated by drugs;
performing of special manipulation (drugs administration into a tumor, etc.)
powdering of tablets for liquid drugs preparation.
2. Rules for HOD transportation;
3. Standards of HOD preparation for therapeutic usage;
4. Rules of HOD therapeutic use;
5. Code of good practice with HOD wastes;
6. Rules for individual protective measures use during
work with HOD;
7. Information about absolute and relative health state
contraindications for medical staff at work with HOD.
Warning signs about carcinogenic danger should be writ-
ten and entrance of people into hospital who have not com-
pleted occupational courses and do not have special permis-
sion should be limited.
It is necessary to list employees eligible to work with
HOD in order to limit a number of people who contact with
them. Duration of work with HOD as well as with patients
in the course of chemotherapy and after it should be within
certain chronological framework. Working time should be
minimized especially due to absence of thresholds in carcino-
genesis development.
Medical staff eligible to work with HOD has to follow the
rules of safety work, sanitary cleaning of premises, conduct-
ing of chemotherapy, nursing of patients after chemotherapy,
collecting, keeping and utilization of dangerous samples.
General requirements for occupational safety of junior
medical staff during receiving, keeping, medical usage and
dealing with HOD wastes are the following (detailed instruc-
tions are presented in Table 2):
1. Nurses should use individual protective measures in all
cases (respirators, gloves, protective cloth);
2. Using of catheters for HOD injection is preferred;
3. In case of HOD intravenous injection at first it is neces-
sary to inject 0.9% physiological salt solution or other
solvent (without oncogenic drugs) and then addition-
ally administrate medication with HOD using dosing
device;
4. Having finished the injection of HOD via infusion set
it is necessary to administrate 0.9% physiological salt
solution or other solvent for final cleaning of system
from HOD.
5. All wastes should be sorted and utilized according to
rules of occupational safety during work with HOD;
6. All materials contacting with HOD and biological liq-
uids of patients before and after chemotherapy like
urine, blood, sweat, vomiting mass might be marked
as “dangerous”. Flasks, infusion sets and dosing de-
vices for intravenous HOD injection, medical syringes,
gloves, clothes, swaddling-clothes, diapers etc. refer to
such materials;
7. Disinfection, laundry of clothes and linen contaminated
by carcinogenic drugs should be done separately from
each other;
8. Medical staff who contact with HOD or their wastes
are provided with individual protective measures such
as cotton medical overall, caps, rubber cover slats, latex
gloves, goggles, face masks.
Contraindications for medical staff at work with HOD can
be seen in Table 3.
Conclusions and prospects for further
research
Introduction of questions related to occupational safety dur-
ing work with anticancer drugs into the discipline “Occupa-
tional safety in the field” for junior specialists will allow to
decrease the level of work-related diseases and other profes-
sional pathology among junior medical staff during work with
HOD.
The prospects of further researches involve developing of
diet and preventive nutrition for junior medical staff work-
ing with anticancer drugs development of new measures and
methods of individual and collective protective measures from
HOD.
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Table 2. Requirements for occupational safety during work with HOD
Activity Requirements for occupational safety
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